Amphastar Pharmaceuticals
AMPH
AMPH
218 hedge funds and large institutions have $1.13B invested in Amphastar Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 76 increasing their positions, 82 reducing their positions, and 26 closing their positions.
Holders
218
Holders Change
+5
Holders Change %
+2.35%
% of All Funds
3.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
32
Increased
76
Reduced
82
Closed
26
Calls
$2.24M
Puts
$581K
Net Calls
+$1.65M
Net Calls Change
+$628K
Top Buyers
Top Sellers
| 1 |
1
BlackRock
New York
|
$246M |
| 2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$17.6M |
| 3 |
3
Pacer Advisors
Malvern,
Pennsylvania
|
$0 |
| 4 |
4
Arrowstreet Capital
Boston,
Massachusetts
|
$2.79M |
| 5 |
5
Morgan Stanley
New York
|
$19.5M |
